StockVS

Evolution Global Acquisition Corp (EVOXU) 股票分析

金融服务

Evolution Global Acquisition Corp

$10.17

+$0.00 (+0.00%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Evolution Global Acquisition Corp is a shell company incorporated in 2025 that does not maintain significant operational activities, focusing instead on executing business combinations such as mergers, amalgamations, share exchanges, asset acquisitions, or reorganizations with one or more target businesses. The enterprise operates within the Financial Services sector and specifically within the industry classified as Shell Companies, a designation that implies the entity currently exists primarily as a vehicle for future corporate activity rather than as an operating business with established products or services. Regarding its scale, the company's market capitalization and annual revenue are not available for disclosure, and the number of employees is listed as N/A, indicating a lack of substantial workforce or traditional operational footprint at this stage. The absence of reported market cap and revenue figures suggests that the company has not yet generated commercial income or established a trading valuation based on earnings, positioning it as a pre-transaction entity awaiting a definitive merger agreement to establish its economic presence and scale.

财务健康

The company reports a Net Income (TTM) of $-8,226,470, while both Revenue (TTM) and EBITDA figures are unavailable; the significant negative net income relative to zero revenue indicates a cost structure dominated by organizational expenses rather than operational costs tied to sales generation. Free Cash Flow is not reported, which means there is no available data to assess the company's immediate financial flexibility or its ability to fund operations without external capital injections. All three margin metrics—Gross Margin, Operating Margin, and Profit Margin—are recorded at 0.0%, reflecting the fact that the company has no significant revenue streams to generate gross profit, operating profit, or net profit from its current activities. The balance sheet shows a debt obligation of $241,107 against a cash position that is not specified, and the Debt to Equity ratio is unavailable, preventing a direct comparison of leverage levels between liabilities and shareholders' equity. Despite the debt presence, the Current Ratio stands at 7.23, which indicates a strong short-term liquidity position where current assets substantially exceed current liabilities, suggesting the company can comfortably meet its obligations if sufficient liquid assets exist. Return on Equity and Return on Assets are both listed as N/A, revealing that management effectiveness cannot be measured through these return metrics in the absence of meaningful equity or asset bases to generate returns on.

估值评估

The Trailing P/E and Forward P/E ratios are both unavailable, making it impossible to analyze the difference between them or to infer any expected earnings trajectory for the entity. The Price to Book ratio is stated as -38.12, a negative figure that indicates the market valuation is significantly below the book value or that the book value is negative due to the accumulated net losses, rather than representing a market premium over tangible assets. Price to Sales and EV/EBITDA metrics are not available, so no alternative valuation comparisons can be drawn to suggest how the market values the company relative to its sales or enterprise earnings. The 52-Week High is recorded at $10.30 and the 52-Week Low at $10.05; without a specific current share price provided in the facts, the exact percentage deviation from this range cannot be calculated, though the narrow trading band suggests limited price movement over the past year. Beta is listed as N/A, meaning volatility data relative to the broader market is not disclosed, and therefore no conclusion can be drawn regarding the stock's sensitivity to market fluctuations.

Growth & Income

Revenue Growth (YoY) and Earnings Growth (YoY) are both unavailable, precluding any analysis of whether earnings are growing faster or slower than revenue or the determination of a growth trajectory. Since the company does not pay dividends, there is no Dividend Yield or Payout Ratio to report, confirming that the company reinvests any potential future earnings or proceeds from business combinations into growth initiatives rather than distributing cash to shareholders. The overall growth and income profile is characterized by a complete lack of historical financial growth data and income generation, as the entity remains in a shell company status focused solely on facilitating future business combinations rather than delivering current financial returns.

同行比较

Evolution Global Acquisition Corp (EVOXU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Evolution Global Acquisition Corp EVOXU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Evolution Global Acquisition Corp的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Evolution Global Acquisition Corp

Evolution Global Acquisition Corp does not have significant operations. It focuses on entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Farmers Branch, Texas.

公司简介以英文显示。

关键指标

市值
N/A
市盈率
N/A
52周最高
$10.30
52周最低
$10.05
平均成交量
801

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States